Hodgkin lymphoma is one of the most curable malignancies, yet older adults experience disproportionately worse outcomes because diagnosis is often delayed and treatment tolerance differs substantially from that of younger patients. From the AAVBC's perspective, value-based care begins with accountable diagnostic stewardship: persistent lymphadenopathy accompanied by unexplained B symptoms should trigger an urgent lymphoma pathway—not empiric antibiotics or prolonged observation. Definitive diagnosis requires an excisional lymph node biopsy rather than fine-needle aspiration, and early referral should explicitly request tissue architecture sufficient for lymphoma subtyping. The highest-value intervention is shortening the time from suspicion to diagnosis before disease advances and treatment options narrow.
Drawing from current NCCN and Lugano Classification guidance, AAVBC's Hodgkin's Lymphoma Quick Reference Guide focuses on the clinical decisions where primary care creates the greatest value. It highlights ICD-10 subtype coding, HCC/RAF mapping, PET-first staging that eliminates routine bone marrow biopsy and guides response-adapted therapy, recognition of older-adult disease patterns, and MEAT documentation supporting timely referral. The guide also prepares PCPs for survivorship care through treatment-informed monitoring for secondary malignancies and late cardiovascular and pulmonary toxicity, while emphasizing geriatric-informed care, including awareness that bleomycin-containing ABVD carries substantially greater toxicity in older adults and that newer frontline approaches may offer safer alternatives for appropriate patients.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of Hodgkin's lymphoma — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Hodgkin lymphoma is one of the most curable malignancies, yet older adults experience disproportionately worse outcomes because diagnosis is often delayed and treatment tolerance differs substantially from that of younger patients. From the AAVBC's perspective, value-based care begins with accountable diagnostic stewardship: persistent lymphadenopathy accompanied by unexplained B symptoms should trigger an urgent lymphoma pathway—not empiric antibiotics or prolonged observation. Definitive diagnosis requires an excisional lymph node biopsy rather than fine-needle aspiration, and early referral should explicitly request tissue architecture sufficient for lymphoma subtyping. The highest-value intervention is shortening the time from suspicion to diagnosis before disease advances and treatment options narrow.
Drawing from current NCCN and Lugano Classification guidance, AAVBC's Hodgkin's Lymphoma Quick Reference Guide focuses on the clinical decisions where primary care creates the greatest value. It highlights ICD-10 subtype coding, HCC/RAF mapping, PET-first staging that eliminates routine bone marrow biopsy and guides response-adapted therapy, recognition of older-adult disease patterns, and MEAT documentation supporting timely referral. The guide also prepares PCPs for survivorship care through treatment-informed monitoring for secondary malignancies and late cardiovascular and pulmonary toxicity, while emphasizing geriatric-informed care, including awareness that bleomycin-containing ABVD carries substantially greater toxicity in older adults and that newer frontline approaches may offer safer alternatives for appropriate patients.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of Hodgkin's lymphoma — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
